Mizuho Securities USA’s ResMed RMD Stock Holding History

Mizuho Securities USA’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.98M	Sell	8,807 -1,821	-17%	-$454K	0.05%	386
2025 Q4	$2.72M	Sell	10,628 -36	-0.3%	-$9.21K	0.04%	348
2025 Q3	$2.93M	Buy	10,664 +526	+5%	+$144K	0.06%	319
2025 Q2	$2.62M	Sell	10,138 -1,622	-14%	-$387K	0.06%	329
2025 Q1	$2.63M	Sell	11,760 -2,153	-15%	-$503K	0.06%	329
2024 Q4	$3.18M	Buy	13,913 +4,385	+46%	+$1.06M	0.06%	309
2024 Q3	$2.33M	Sell	9,528 -1,803	-16%	-$403K	0.05%	323
2024 Q2	$2.17M	Buy	+11,331	New	+$2.3M	0.05%	352

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mizuho Securities USA's RMD Position: Q1 2026 in Review

Mizuho Securities USA reduced its ResMed (RMD) stake by 17% in Q1 2026, selling an estimated $454K and leaving 8,807 shares worth $1.98M. The position accounts for 0.05% of the portfolio, ranked #386.

Mizuho Securities USA first reported a position in RMD in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.18M in Q4 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Mizuho Securities USA held 8,807 shares of ResMed worth $1.98M as of Q1 2026.
Mizuho Securities USA sold 1,821 ResMed shares in Q1 2026, an estimated $454K.
ResMed made up 0.05% of Mizuho Securities USA's portfolio in Q1 2026, its #386 holding.
Mizuho Securities USA first reported a position in ResMed in Q2 2024 and has held it in 8 quarters since.
Mizuho Securities USA's ResMed position peaked at $3.18M in Q4 2024.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Mizuho Securities USA's 13F filing for Q1 2026, filed 11 May 2026.